17/02/2011
Further to the announcement made on 12 January 2011, the Company announces that at the High Court hearing that took place on 16 February 2011, approval for the reduction of capital was granted.
Following this approval, the placing of 300,000,000 new ordinary shares (the “Placing Shares”) of 0.01 pence in the Company at 0.5 pence per share raising £1,500,000 before expenses, has become unconditional.
The Placing Shares will rank pari passu with the Company’s existing shares in all respects. Application has been made for the Placing Shares to be admitted to trading on AIM and dealings in these shares will commence on 18 February 2011.
Following the placing, the issued share capital of the Company will comprise 389,446,548 ordinary shares of 0.01 pence each.
Enquiries:
ReGen Therapeutics Plc
Percy Lomax
+44 20 7153 4920
Cairn Financial Advisers LLP
Nominated Adviser
Liam Murray / Avi Robinson
+44 20 7148 7900
Alexander David Securities Limited
Broker
David Scott / Nick Bealer
+44 20 7448 9820